Product Overview
Our customers can benefit from our end-to-end comprehensive eCOA package or create value by selecting certain elements that meet specific requirements. Our solution can be used stand-alone as it is independent of any specific eClinical technologies such as EDC systems, but it can also be integrated into any existing eClinical software landscape. It has been created to collect any reported outcome data in a streamlined, complaint, and efficient way.
Ensure success by using robust and adaptable technology
We support a bring-your-own-device (BYOD) strategy – on any device. We assist our customers with scientific services to review their protocols, proposing standard questionnaires/ eDiaries that address their primary and secondary endpoints, or building a custom offer. We then validate the questionnaires/eDiaries against industry standards and medical requirements, and then set them up in our eCOA application.
Deployment
- Web based
- Cloud Hosted
Pricing
- Subscription
- License Fee
More Information
Highly configurable
Build complex electronic data capture forms for use during in clinic or virtual visits. EvidentIQ eCOA data capture forms include all standard form fields, text, and scale based- questions, image hotspots, smart notifications, and data checks required for most protocols.
Ensure data integrity/quality
eCOA enables real-time data streams and accurate timestamping and data entries, which improve the quality of the data coming in for a given study. In addition, this data is encrypted and protected, ensuring patient data integrity.
About the company
Leveraging more than 50 years of combined experience providing innovative and creative ways to conduct clinical trials. End-to-end eClinical Solution
Meeting increasing customer demand across clinical operations and clinical data management needs with a suite of applications within a single integrated cloud platform, including EDC, CTMS, eTMF, eCOA, coding, remote monitoring, RBM, RTSM, Payments and eFeasibility. Geographical Reach
In-country patient communities platform in North America and Western Europe (EU5) and ability to conduct studies at a broader scale (LatAM, Asia…). Regulatory expertise to support broader geographical studies.
